See more : Trive Property Group Berhad (0118.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Reliq Health Technologies Inc. (RQHTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliq Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Aiadvertising Inc. (CLWD) Income Statement Analysis – Financial Results
- BF Utilities Limited (BFUTILITIE.BO) Income Statement Analysis – Financial Results
- Focus Graphite Inc. (FCSMF) Income Statement Analysis – Financial Results
- Danske Invest Nordiske Virksomhedsobligationer Akk KL (DKINVO.CO) Income Statement Analysis – Financial Results
- United Rentals, Inc. (0LIY.L) Income Statement Analysis – Financial Results
Reliq Health Technologies Inc. (RQHTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.reliqhealth.com
About Reliq Health Technologies Inc.
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.55M | 1.46M | 1.14M | 181.91K | 2.27M | 182.65K | 536.20K | 31.62K | 29.74K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Cost of Revenue | 3.25M | 7.26M | 7.52M | 5.84M | 12.24M | 960.12K | 544.48K | 1.85K | 93.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 5.30M | -5.80M | -6.38M | -5.66M | -9.97M | -777.47K | -8.28K | 29.77K | -63.58K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Gross Profit Ratio | 61.99% | -396.52% | -558.27% | -3,112.71% | -439.17% | -425.65% | -1.54% | 94.15% | -213.83% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
Research & Development | 2.22M | 1.73M | 1.72M | 5.15M | 1.42M | 719.41K | 447.23K | 270.20K | 432.89K | 510.83K | 172.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.03M | 10.11M | 8.82M | 7.33M | 12.00M | 1.80M | 1.84M | 4.06M | 331.33K | 517.42K | 398.62K | 812.67K | 769.08K | 663.98K | 44.57K | 0.00 | 0.00 |
Selling & Marketing | 492.65K | 515.70K | 353.48K | 274.48K | 381.68K | 311.50K | 354.60K | 211.65K | 11.24K | 10.30K | 11.67K | 42.26K | 177.38K | 31.29K | 412.00 | 0.00 | 0.00 |
SG&A | 10.52M | 4.10M | 3.06M | 2.64M | 2.40M | 1.30M | 1.97M | 4.27M | 331.33K | 517.42K | 410.29K | 854.94K | 946.46K | 695.27K | 44.98K | 109.46K | 1.00K |
Other Expenses | 888.82K | -5.64K | -58.35K | -34.40K | -32.97K | 189.88K | 18.25K | 0.00 | 0.00 | 0.00 | -2.02K | -3.61K | -28.09K | 1.67K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 13.63M | 5.83M | 4.84M | 7.82M | 3.82M | 2.02M | 2.42M | 4.54M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Cost & Expenses | 16.88M | 13.09M | 12.37M | 13.67M | 16.06M | 2.98M | 2.96M | 4.55M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Interest Income | 76.61K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 43.81K | 11.00 | 2.24K | 5.74K | 1.73K | 12.31K | 13.99K | 12.69K | 274.00 |
Interest Expense | 35.28K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 0.00 | 1.17K | 813.00 | 1.11K | 698.00 | 631.00 | 123.00 | 113.00 | 0.00 |
Depreciation & Amortization | 115.29K | 125.76K | 445.41K | 634.16K | 634.16K | 2.05K | 6.17K | 6.17K | 2.18K | 1.49K | 938.00 | 1.94K | 639.00 | 11.28K | 123.00 | 0.00 | 0.00 |
EBITDA | -8.02M | -11.51M | -10.78M | -12.85M | -12.65M | -2.80M | -2.42M | -2.40M | -928.85K | 367.16K | 223.33K | -854.94K | -972.83K | -684.63K | -44.98K | -109.46K | -726.00 |
EBITDA Ratio | -93.79% | -786.98% | -943.01% | -7,064.61% | -607.62% | -1,532.76% | -451.51% | -14,261.37% | 311.96% | 593.03% | 14,918.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Operating Income | -8.30M | -11.63M | -11.22M | -13.49M | -13.79M | -2.80M | -2.43M | -2.45M | -317.35K | -518.90K | -526.04K | -857.99K | -947.80K | -695.90K | -45.10K | -109.46K | -726.00 |
Operating Income Ratio | -97.01% | -795.58% | -981.98% | -7,413.23% | -607.62% | -1,533.88% | -452.66% | -7,764.22% | -1,067.26% | -838.13% | -35,139.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Total Other Income/Expenses | 124.77K | -101.19K | 33.51K | 301.31K | -163.28K | 340.54K | -412.46K | -2.10M | -440.25K | -512.27K | -748.97K | 2.13K | -413.04K | -39.36K | 0.00 | 0.00 | 726.00 |
Income Before Tax | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.36M | -735.26K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 4.00 | 239.11K | 2.00 | -2.05K | 3.00 | 1.00 | -2.02M | 424.09K | 884.57K | 747.99K | -79.38K | -138.88K | -8.98K | -13.99K | 96.88K | 726.00 |
Net Income | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.22M | -735.26K | -31.11K | -96.88K | -726.00 |
Net Income Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
EPS | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
EPS Diluted | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
Weighted Avg Shares Out | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Weighted Avg Shares Out (Dil) | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Reliq Health Technologies, Inc. Provides Corporate Update and Overview of Expanded CMS Coverage for Remote Patient Monitoring for 2022
Reliq Health Technologies, Inc. Announces New Contracts with Three US Physician Practices
Reliq Health Technologies, Inc. Announces Three New Contracts with Home Health Agencies in Texas
Reliq Health Technologies, Inc. Provides Update on Significant Expansion of Texas Medicaid Coverage, more than Doubling the Eligible Patient Population for Reliq in TX
Reliq Health Technologies, Inc. Announces New Contract in Nigeria to Provide iUGO Care and iUGO Voice to Chronic Disease Patients
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q3 2021 Results - Earnings Call Transcript
Reliq Health Technologies, Inc. Files Q3 FY2021 Financial Statements, Provides Corporate Update
Reliq Health Technologies, Inc. Announces that it has Resumed Onboarding at Remote Health Clinics and Federally Qualified Health Centers as US COVID Cases Drop
Reliq Health Technologies, Inc. Announces New Skilled Nursing Facility Clients, Expansion of Care Management Team
Reliq Health Technologies, Inc. Announces Implementation of FHIR Standard for Interoperability to Address New CMS Regulations, Hires New Chief Technology & Innovation Officer
Source: https://incomestatements.info
Category: Stock Reports